Agenus Company Leadership
| AGEN Stock | USD 3.34 0.48 16.78% |
Agenus employs about 389 people. The company is managed by 17 executives with a total tenure of roughly 42 years, averaging almost 2.0 years of service per executive, having 22.88 employees per reported executive. Analysis of Agenus' management performance can provide insight into the firm performance.
| Garo Armen Chairman Founder, Executive Chairman, CEO and Chairman of Bus. and Devel. Advisory Committee |
Agenus |
Agenus' Workforce Through the Years
Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with Agenus' future performance. Based on our forecasts, it is anticipated that Agenus will maintain a workforce of about 390 employees by December 2024.Agenus Management Team Effectiveness
The company has return on total asset (ROA) of (0.2195) % which means that it has lost $0.2195 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (12.7883) %, meaning that it created substantial loss on money invested by shareholders. Agenus' management efficiency ratios could be used to measure how well Agenus manages its routine affairs as well as how well it operates its assets and liabilities. As of the 25th of November 2024, Return On Equity is likely to grow to 1.61, while Return On Tangible Assets are likely to drop (0.91). At this time, Agenus' Asset Turnover is very stable compared to the past year.As of the 25th of November 2024, Common Stock Shares Outstanding is likely to grow to about 18.8 M, though Net Loss is likely to grow to (188.3 M).
Agenus Workforce Comparison
Agenus Inc is rated third in number of employees category among its peers. The total workforce of Health Care industry is presently estimated at about 2,438. Agenus retains roughly 389 in number of employees claiming about 16% of equities under Health Care industry.
The company has Profit Margin (PM) of (1.42) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (1.33) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $1.33. Agenus Insider Trading History
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Agenus insiders, such as employees or executives, is commonly permitted as long as it does not rely on Agenus' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Agenus insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
| Buy/Sell Ratio | # Purchases Trades | # Sales Trades | Total Shares Purchased | Total Shares Sold | |
|---|---|---|---|---|---|
| 2024-06-01 | 9.5 | 19 | 2 | 369,480 | 37,500 |
| 2023-12-01 | 11.0 | 11 | 1 | 208,306 | 1,250 |
| 2023-03-01 | 13.0 | 13 | 1 | 3,615,727 | 37,500 |
| 2022-03-01 | 5.6667 | 17 | 3 | 3,338,235 | 146,179 |
| 2021-09-01 | 1.75 | 7 | 4 | 159,360 | 228,968 |
| 2021-06-01 | 7.25 | 29 | 4 | 4,000,664 | 93,501 |
| 2021-03-01 | 5.0 | 10 | 2 | 36,659 | 400,000 |
| 2020-12-01 | 4.0 | 24 | 6 | 3,896,864 | 248,299 |
| 2020-06-01 | 2.6 | 26 | 10 | 491,798 | 1,591,176 |
| 2019-12-01 | 3.0 | 15 | 5 | 2,935,347 | 547,715 |
| 2019-09-01 | 9.0 | 9 | 1 | 432,287 | 50,000 |
| 2019-06-01 | 23.0 | 23 | 1 | 3,835,742 | 15,000 |
| 2019-03-01 | 1.5 | 3 | 2 | 19,558 | 145,000 |
| 2018-12-01 | 6.0 | 6 | 1 | 254,714 | 6,500 |
| 2018-09-01 | 2.0 | 4 | 2 | 312,102 | 225,000 |
| 2018-06-01 | 9.5 | 19 | 2 | 2,014,523 | 140,974 |
| 2018-03-01 | 1.25 | 10 | 8 | 108,021 | 431,800 |
| 2017-12-01 | 2.1667 | 13 | 6 | 354,230 | 327,737 |
| 2017-09-01 | 1.0 | 1 | 1 | 4,375 | 150,000 |
| 2017-06-01 | 3.5 | 21 | 6 | 505,459 | 36,772 |
| 2017-03-01 | 2.5714 | 18 | 7 | 12,323,211 | 396,250 |
| 2016-12-01 | 0.6667 | 2 | 3 | 3,665 | 249,156 |
| 2016-06-01 | 4.0909 | 45 | 11 | 2,339,059 | 191,238 |
| 2016-03-01 | 4.0 | 4 | 1 | 207,960 | 150,000 |
| 2015-12-01 | 0.6 | 3 | 5 | 84,753 | 442,076 |
| 2015-09-01 | 11.0 | 11 | 1 | 294,649 | 60,500 |
| 2015-06-01 | 3.3333 | 10 | 3 | 1,851,367 | 1,113,210 |
| 2015-03-01 | 0.6667 | 12 | 18 | 410,544 | 2,504,655 |
| 2014-09-01 | 3.0 | 3 | 1 | 10,856 | 32,500 |
| 2014-06-01 | 5.0 | 15 | 3 | 302,931 | 394,846 |
| 2014-03-01 | 3.5 | 14 | 4 | 1,203,232 | 57,850 |
| 2013-06-01 | 8.0 | 16 | 2 | 491,771 | 32,500 |
| 2013-03-01 | 3.6667 | 11 | 3 | 20,596 | 3,987 |
| 2012-12-01 | 12.0 | 12 | 1 | 269,451 | 288.00 |
| 2012-09-01 | 2.8333 | 17 | 6 | 113,019 | 5,263 |
| 2012-06-01 | 3.1 | 31 | 10 | 869,769 | 92,168 |
| 2012-03-01 | 10.0 | 20 | 2 | 131,981 | 500,833 |
| 2011-12-01 | 0.56 | 14 | 25 | 36,428 | 61,208 |
| 2010-12-01 | 2.75 | 11 | 4 | 85,218 | 10,665 |
| 2010-09-01 | 2.4286 | 17 | 7 | 627,872 | 16,336 |
| 2010-06-01 | 8.6667 | 26 | 3 | 306,752 | 8,615 |
| 2010-03-01 | 3.4286 | 24 | 7 | 1,993,296 | 472,688 |
| 2009-09-01 | 0.6176 | 21 | 34 | 1,440,370 | 1,172,713 |
| 2009-06-01 | 15.0 | 15 | 1 | 592,099 | 171,861 |
| 2009-03-01 | 4.1667 | 25 | 6 | 812,910 | 111,046 |
| 2008-09-01 | 5.5 | 22 | 4 | 750,154 | 3,365,181 |
| 2008-06-01 | 6.5 | 13 | 2 | 147,701 | 25,000 |
| 2008-03-01 | 6.6667 | 20 | 3 | 2,059,562 | 28,127 |
| 2007-09-01 | 2.0 | 6 | 3 | 585,895 | 107,267 |
| 2007-06-01 | 11.0 | 11 | 1 | 136,970 | 0.00 |
| 2007-03-01 | 11.0 | 22 | 2 | 408,129 | 70,000 |
| 2006-12-01 | 0.8 | 4 | 5 | 18,267 | 159,500 |
| 2006-03-01 | 2.75 | 11 | 4 | 331,939 | 174,830 |
| 2005-12-01 | 5.0 | 5 | 1 | 6,522 | 25,000 |
| 2005-09-01 | 5.0 | 5 | 1 | 5,480 | 125,000 |
| 2005-03-01 | 8.0 | 8 | 1 | 438,470 | 6,800 |
| 2004-09-01 | 1.0 | 1 | 1 | 25,000 | 20,000 |
| 2004-03-01 | 2.0 | 4 | 2 | 375,000 | 65,000 |
Agenus Notable Stakeholders
An Agenus stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Agenus often face trade-offs trying to please all of them. Agenus' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Agenus' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Garo Armen | Founder, Executive Chairman, CEO and Chairman of Bus. and Devel. Advisory Committee | Profile | |
| Christine Klaskin | Principal Accounting Officer and VP of Fin. | Profile | |
| Julie DeSander | Chief Officer | Profile | |
| Alfred Dadson | Chief Officer | Profile | |
| Eric Humes | Chief Officer | Profile | |
| Regina Grebla | VP Communications | Profile | |
| Dr MBA | Chief Officer | Profile | |
| John Castle | Head Bioinformatics | Profile | |
| Zack Armen | Head Development | Profile | |
| Dhan Chand | Scientific Discovery | Profile | |
| Jennifer Buell | Pres Therapeutics | Profile | |
| Nils MD | Chief Officer | Profile | |
| Tracy Clemente | Chief Officer | Profile | |
| Todd MD | Member Advisor | Profile | |
| Craig Winter | Chief Officer | Profile | |
| Robin JD | Chief Officer | Profile | |
| Stephanie Fagan | Chief Officer | Profile |
About Agenus Management Performance
The success or failure of an entity such as Agenus Inc often depends on how effective the management is. Agenus management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Agenus management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Agenus management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.86) | (0.91) | |
| Return On Capital Employed | (2.75) | (2.61) | |
| Return On Assets | (0.78) | (0.82) | |
| Return On Equity | 1.53 | 1.61 |
Agenus Workforce Analysis
Traditionally, organizations such as Agenus use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Agenus within its industry.Agenus Manpower Efficiency
Return on Agenus Manpower
| Revenue Per Employee | 401.8K | |
| Revenue Per Executive | 9.2M | |
| Net Loss Per Employee | 631.8K | |
| Net Loss Per Executive | 14.5M |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Agenus Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Agenus. If investors know Agenus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Agenus listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (11.02) | Revenue Per Share 7.808 | Quarterly Revenue Growth 0.033 | Return On Assets (0.22) | Return On Equity (12.79) |
The market value of Agenus Inc is measured differently than its book value, which is the value of Agenus that is recorded on the company's balance sheet. Investors also form their own opinion of Agenus' value that differs from its market value or its book value, called intrinsic value, which is Agenus' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Agenus' market value can be influenced by many factors that don't directly affect Agenus' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Agenus' value and its price as these two are different measures arrived at by different means. Investors typically determine if Agenus is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Agenus' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.